UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

The microbiota in cirrhosis and its role in hepatic decompensation

Journal of hepatology, 2021-07, Vol.75 (Suppl 1), p.S67-S81

2021

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation

Journal of clinical and experimental hepatology, 2015-03, Vol.5 (Suppl 1), p.S7-S20

2015

Link zum Volltext

Verfügbarkeit prüfen

Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list

Alimentary pharmacology & therapeutics, 2019-08, Vol.50 (4), p.435-441

2019

Link zum Volltext

Verfügbarkeit prüfen

Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis

Hepatology (Baltimore, Md.), 2010-03, Vol.51 (3), p.1062-1069

2010

Link zum Volltext

Verfügbarkeit prüfen

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis

Journal of hepatology, 2004-02, Vol.40 (2), p.247-254

2004

Link zum Volltext

Verfügbarkeit prüfen

Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus

The American journal of gastroenterology, 2020-07, Vol.115 (7), p.989-1002

2020

Link zum Volltext

Verfügbarkeit prüfen

Regulation, risk and safety of Faecal Microbiota Transplant

Infection prevention in practice, 2020-09, Vol.2 (3), p.100069-100069, Article 100069

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating neutrophil dysfunction in acute liver failure

Hepatology (Baltimore, Md.), 2013-03, Vol.57 (3), p.1142-1152

2013

Link zum Volltext

Verfügbarkeit prüfen

The 6-month abstinence rule in liver transplantation

The Lancet (British edition), 2010-07, Vol.376 (9737), p.216-217

2010

Link zum Volltext

Verfügbarkeit prüfen

Ammonia – an enduring foe – What evaluating whole body ammonia metabolism can teach us about cirrhosis and therapies treating hepatic encephalopathy

Journal of hepatology, 2023-08, Vol.79 (2), p.266-268

2023

Link zum Volltext

Verfügbarkeit prüfen

Let's Have Some Clarity on Academic Parity

The American journal of gastroenterology, 2023-02, Vol.118 (2), p.185-187

2023

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)

Infectious disease reports, 2023-05, Vol.15 (3), p.238-254

2023

Link zum Volltext

Verfügbarkeit prüfen

Gut-derived systemic inflammation as a driver of depression in chronic liver disease

Journal of hepatology, 2022-03, Vol.76 (3), p.665-680

2022

Link zum Volltext

Verfügbarkeit prüfen

Statins: A Panacea to Reduce Mortality in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma?

Liver transplantation, 2022-03, Vol.28 (3), p.357-358

2022

Link zum Volltext

Verfügbarkeit prüfen

Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial

BMJ open, 2020-05, Vol.10 (5), p.e038847

2020

Link zum Volltext

Verfügbarkeit prüfen

A Turning point in Hepatology? EASL Reflects on the First Approved Drug for MASH

Journal of hepatology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

Critical care medicine, 2016-01, Vol.44 (1), p.43-53

2016

Link zum Volltext

Verfügbarkeit prüfen

Endotoxemia produces coma and brain swelling in bile duct ligated rats

Hepatology (Baltimore, Md.), 2007-06, Vol.45 (6), p.1517-1526

2007

Link zum Volltext

Verfügbarkeit prüfen

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

Nature (London), 2019-11, Vol.575 (7783), p.505-511

2019

Link zum Volltext

Verfügbarkeit prüfen

The rise and fall and rise again of ammonia as a therapeutic target in HE

Hepatology (Baltimore, Md.), 2022-05, Vol.75 (5), p.1078-1080

2022

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and hepatic encephalopathy

Archives of biochemistry and biophysics, 2013-08, Vol.536 (2), p.189-196

2013

Link zum Volltext

Verfügbarkeit prüfen

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy

Journal of hepatology, 2022-09, Vol.77 (3), p.807-824

2022

Link zum Volltext

Verfügbarkeit prüfen

Erroneous Ammonia Measurement is Not Synonymous With a Lack of Efficacy of Ammonia-Lowering Therapies in Hepatic Encephalopathy

Clinical gastroenterology and hepatology, 2021-11, Vol.19 (11), p.2456-2457

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis

Journal of hepatology, 2022-12, Vol.77 (6), p.1554-1563

2022

Link zum Volltext

Verfügbarkeit prüfen

The assessment and management of cirrhotic patients with encephalopathy

United European gastroenterology journal, 2024-03, Vol.12 (2), p.187-193

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(133)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The microbiota in cirrhosis and its role in hepatic decompensation

Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation

Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list

Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis

Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus

Regulation, risk and safety of Faecal Microbiota Transplant

Circulating neutrophil dysfunction in acute liver failure

The 6-month abstinence rule in liver transplantation

Ammonia – an enduring foe – What evaluating whole body ammonia metabolism can teach us about cirrhosis and therapies treating hepatic encephalopathy

Let's Have Some Clarity on Academic Parity

Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)

Gut-derived systemic inflammation as a driver of depression in chronic liver disease

Statins: A Panacea to Reduce Mortality in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma?

Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial

A Turning point in Hepatology? EASL Reflects on the First Approved Drug for MASH

Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

Endotoxemia produces coma and brain swelling in bile duct ligated rats

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

The rise and fall and rise again of ammonia as a therapeutic target in HE

Inflammation and hepatic encephalopathy

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy

Erroneous Ammonia Measurement is Not Synonymous With a Lack of Efficacy of Ammonia-Lowering Therapies in Hepatic Encephalopathy

Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis

The assessment and management of cirrhotic patients with encephalopathy

Suchergebnisse filtern